167 related articles for article (PubMed ID: 35393764)
1. Antagonist of Chrna1 prevents the pathogenesis of primary focal hyperhidrosis.
Lin JB; Lin NL; Li X; Kang MQ
Ann Clin Transl Neurol; 2022 Jun; 9(6):786-794. PubMed ID: 35393764
[TBL] [Abstract][Full Text] [Related]
2. CHRNA1 promotes the pathogenesis of primary focal hyperhidrosis.
Lin JB; Kang MQ; Huang LP; Zhuo Y; Li X; Lai FC
Mol Cell Neurosci; 2021 Mar; 111():103598. PubMed ID: 33476802
[TBL] [Abstract][Full Text] [Related]
3. PAI1 inhibits the pathogenesis of primary focal hyperhidrosis by targeting CHRNA1.
Chen JF; Lin M; Li X; Lin JB
Orphanet J Rare Dis; 2023 Jul; 18(1):205. PubMed ID: 37542348
[TBL] [Abstract][Full Text] [Related]
4. Involvement of aquaporin 5 and Na-K-2Cl cotransporter 1 in the pathogenesis of primary focal hyperhidrosis: evidence from the primary sweat gland cell culture.
Lin J; Lin M; Du Q; Tu Y; Chen J
Am J Physiol Cell Physiol; 2024 Jan; 326(1):C206-C213. PubMed ID: 38047298
[TBL] [Abstract][Full Text] [Related]
5. Involvement of activin a receptor type 1 (ACVR1) in the pathogenesis of primary focal hyperhidrosis.
Lin JB; Chen JF; Lai FC; Li X; Xie JB; Tu YR; Kang MQ
Biochem Biophys Res Commun; 2020 Jul; 528(2):299-304. PubMed ID: 32473755
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of AQP5 Was Detected in Axillary Sweat Glands of Primary Focal Hyperhidrosis Patients.
Du Q; Lin M; Yang JH; Chen JF; Tu YR
Dermatology; 2016; 232(2):150-5. PubMed ID: 26930592
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of ITGB6 in primary palmar hyperhidrosis.
Lin JB; Chen YX; Lin NL; Li X
Adv Clin Exp Med; 2023 Dec; 32(12):1413-1422. PubMed ID: 37212774
[TBL] [Abstract][Full Text] [Related]
8. Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis.
Pariser DM; Krishnaraja J; Tremblay TM; Rubison RM; Love TW; McGraw BF
J Drugs Dermatol; 2017 Feb; 16(2):127-132. PubMed ID: 28300854
[TBL] [Abstract][Full Text] [Related]
9. Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin.
Swartling C; Naver H; Pihl-Lundin I; Hagforsen E; Vahlquist A
J Am Acad Dermatol; 2004 Nov; 51(5):739-45. PubMed ID: 15523352
[TBL] [Abstract][Full Text] [Related]
10. Functional requirement of aquaporin-5 in plasma membranes of sweat glands.
Nejsum LN; Kwon TH; Jensen UB; Fumagalli O; Frøkiaer J; Krane CM; Menon AG; King LS; Agre PC; Nielsen S
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):511-6. PubMed ID: 11773623
[TBL] [Abstract][Full Text] [Related]
11. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
Kreyden OP; Scheidegger EP
Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
[TBL] [Abstract][Full Text] [Related]
12. Topiramate reduced sweat secretion and aquaporin-5 expression in sweat glands of mice.
Ma L; Huang YG; Deng YC; Tian JY; Rao ZR; Che HL; Zhang HF; Zhao G
Life Sci; 2007 Jun; 80(26):2461-8. PubMed ID: 17521680
[TBL] [Abstract][Full Text] [Related]
13. Localization of aquaporin-5 in sweat glands and functional analysis using knockout mice.
Song Y; Sonawane N; Verkman AS
J Physiol; 2002 Jun; 541(Pt 2):561-8. PubMed ID: 12042359
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of competitive antagonism by cisatracurium of embryonic and adult nicotinic acetylcholine receptors.
Demazumder D; Dilger JP
Mol Pharmacol; 2001 Oct; 60(4):797-807. PubMed ID: 11562443
[TBL] [Abstract][Full Text] [Related]
15. Sudomotor function in familial dysautonomia.
Bickel A; Axelrod FB; Marthol H; Schmelz M; Hilz MJ
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):275-9. PubMed ID: 14742604
[TBL] [Abstract][Full Text] [Related]
16. Effects of non-pharmacological sympathetic sudomotor denervation on sweating in humans with essential palmar hyperhidrosis.
Noppen M; Sevens C; Vincken WG
Clin Biochem; 1997 Mar; 30(2):171-5. PubMed ID: 9127700
[TBL] [Abstract][Full Text] [Related]
17. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A.
Glaser DA
J Drugs Dermatol; 2004; 3(6):627-31. PubMed ID: 15624745
[TBL] [Abstract][Full Text] [Related]
18. Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients.
Lawrence CM; Lonsdale Eccles AA
Br J Dermatol; 2006 Jul; 155(1):115-8. PubMed ID: 16792762
[TBL] [Abstract][Full Text] [Related]
19. [Toxin treatment of sweat pearls. A review of the treatment of hyperhidrosis with a special view of a new therapy option using botulinum toxin A].
Kreyden OP; Burg G
Schweiz Med Wochenschr; 2000 Jul; 130(29-30):1084-90. PubMed ID: 10971942
[TBL] [Abstract][Full Text] [Related]
20. A novel organotypic 3D sweat gland model with physiological functionality.
Klaka P; Grüdl S; Banowski B; Giesen M; Sättler A; Proksch P; Welss T; Förster T
PLoS One; 2017; 12(8):e0182752. PubMed ID: 28796813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
